Suppr超能文献

17(R),18(S)-环氧二十碳四烯酸,一种强效的二十碳五烯酸 (EPA) 衍生的心肌细胞收缩调节剂:结构-活性关系和稳定类似物。

17(R),18(S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues.

机构信息

Department of Biochemistry, University of Texas Southwestern, Dallas, Texas 75390, United States.

出版信息

J Med Chem. 2011 Jun 23;54(12):4109-18. doi: 10.1021/jm200132q. Epub 2011 Jun 1.

Abstract

17(R),18(S)-epoxyeicosatetraenoic acid [17(R),18(S)-EETeTr], a cytochrome P450 epoxygenase metabolite of eicosapentaenoic acid (EPA), exerts negative chronotropic effects and protects neonatal rat cardiomyocytes against Ca(2+)-overload with EC(50) ≈ 1-2 nM. Structure-activity studies revealed that a cis-Δ(11,12)- or Δ(14,15)-olefin and a 17(R),18(S)-epoxide are minimal structural elements for antiarrhythmic activity whereas antagonist activity was often associated with the combination of a Δ(14,15)-olefin and a 17(S),18(R)-epoxide. Compared with natural material, the agonist and antagonist analogues are chemically and metabolically more robust and several show promise as templates for future development of clinical candidates.

摘要

17(R),18(S)-环氧二十碳四烯酸[17(R),18(S)-EETeTr]是二十碳五烯酸 (EPA) 的细胞色素 P450 环氧化酶代谢物,具有负性变时作用,并以 EC50≈1-2 nM 的浓度保护新生大鼠心肌细胞免受 Ca(2+)-超负荷。结构活性研究表明,顺式Δ(11,12)-或Δ(14,15)-烯烃和 17(R),18(S)-环氧化物是抗心律失常活性的最小结构要素,而拮抗剂活性通常与Δ(14,15)-烯烃和 17(S),18(R)-环氧化物的组合有关。与天然物质相比,激动剂和拮抗剂类似物在化学和代谢上更稳定,并且有几个作为未来临床候选物开发模板的前景。

相似文献

5
CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?CYP 二十烷酸——ω-3 脂肪酸与心脏病之间的新联系?
Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):99-108. doi: 10.1016/j.prostaglandins.2011.09.001. Epub 2011 Sep 16.

引用本文的文献

本文引用的文献

4
New antiarrhythmic drugs for treatment of atrial fibrillation.新型抗心律失常药物治疗心房颤动。
Lancet. 2010 Apr 3;375(9721):1212-23. doi: 10.1016/S0140-6736(10)60096-7. Epub 2010 Mar 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验